1. Non-Coding RNAs Steering the Senescence-Related Progress, Properties, and Application of Mesenchymal Stem Cells
   Jingyi Cai et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
2. The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity
   Huanrong Lan et al, 2021, Cell and Tissue Research CrossRef
3. MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin‐induced cardiotoxicity
   Fatemeh Yarmohammadi et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
4. Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments
   Wanli Sun et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
5. Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate
   Abdelrahman Ibrahim Abushouk et al, 2019, Frontiers in Pharmacology CrossRef
6. Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a
   Wenzheng Xia et al, 2020, Aging CrossRef
7. H2S Donor SPRC Ameliorates Cardiac Aging by Suppression of JMJD3, a Histone Demethylase
   Sha Li et al, 2024, Antioxidants & Redox Signaling CrossRef
8. Cardiac Injury Following Chemo/Radiation Therapy: An Updated Review on Mechanisms and Therapeutic Approaches
   Krishanveer Singh et al, 2023, Current Radiopharmaceuticals CrossRef
9. MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
   Liuying Chen et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
10. Emerging Role of Non-Coding RNAs in Senescence
    Soudeh Ghafouri-Fard et al, 2022, Frontiers in Cell and Developmental Biology CrossRef